Funding Rounds
PEP-Therapy

PEP-Therapy Series A (2021, $3M)

PEP-Therapy

Innovative peptides as targeted therapies for oncology

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $3.29M

Raised Date: 2021-01-01

Investors